The role of hormone replacement therapy in endometrial polyp formation
Authors:
- A. SarginASA. Sargin
- S. KelekciSKS. Kelekci
- H. AytanHAH. Aytan
- O.L. TapisizOTO.L. Tapisiz
- L. MollamahmutogluLML. Mollamahmutoglu
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Recurrent endometrial polyps in postmenopausal breast cancer patients on tamoxifenGynecologic Oncology, 2003
- Ultrasound assessment of endometrial thickness and endometrial polyps in women on hormonal replacement therapyAmerican Journal of Obstetrics and Gynecology, 2003
- Histopathologic features and risk factors for benignity, hyperplasia, and cancer in endometrial polypsAmerican Journal of Obstetrics and Gynecology, 2003
- Significance of secondary ultrasonographic endometrial thickening in postmenopausal tamoxifen‐treated womenCancer, 2002
- Evaluation of endometrial polypsAmerican Journal of Obstetrics and Gynecology, 2002
- Risk factors of endometrial polyps resected from postmenopausal patients with breast carcinoma treated with tamoxifenCancer, 2001
- Endometrial Histopathology in 700 Patients Treated with Tamoxifen for Breast CancerGynecologic Oncology, 2000
- Tamoxifen-Induced Endometrial PolypNew England Journal of Medicine, 1996
- Hysteroscopy and transvaginal sonography in menopausal women receiving hormone replacement therapyThe Journal of the American Association of Gynecologic Laparoscopists, 1996
- Pathology of endometrium treated with tamoxifen.Journal of Clinical Pathology, 1994